BlackRock Throgmorton Trust plc (THRG)

Category UK Small-Cap Equity
star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

557.00p

Buy

558.00p

arrow-up7.00p (+1.27%)

Discount/Premium

-10.99%

Estimated NAV

626.898p

Prices updated at 02 May 2025, 16:36 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The objective is to provide shareholders with long term capital growth and an attractive total return through investment primarily in UK smaller and mid-cap companies traded on the LSE. Company may hold up to 15% of its GA, in securities of companies which are listed or traded on a stock exchange outside the UK. In normal circumstances, company will likely hold a mixture of long and short CFDs and/or comparable equity derivatives that would result in a typical net market exposure of between 100% and 115%.In extremis, the Company could deploy the full 30% of permissible leverage into short CFDs and/or comparable equity derivatives, thereby reducing its overall net market exposure to 70%.
FTSE All-Share
arrow-up1.09%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
25 Apr 2025Sale
25 Apr 2025Sale
25 Apr 2025Purchase
25 Apr 2025Purchase
15 Apr 2025D
15 Apr 2025D
14 Apr 2025D
27 Feb 2025Purchase
17 Oct 2024Purchase
10 Oct 2024Purchase
10 Oct 2024Purchase
30 Sep 2024Sale
30 Sep 2024Purchase
12 Sep 2024D
12 Sep 2024D
12 Sep 2024D
29 Aug 2024D
28 Aug 2024D

Director holdings

Name
chevron-l-regular
chevron-r-regular
Title Amount (No. of shares)
Mrs. Louise Catherine NashNon-Executive Director, Senior Independent Director5,500
Dr. Nigel John BurtonNon-Executive Director17,470
Mr. James Robert WillNon-Executive Director10,000
Ms. Angela Claire LaneNon-Executive Director25,077
Ms. Merryn Somerset WebbNon-Executive Director3,929
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.